First Two Patients Enrolled in National Cancer Institute Trial of the Ability of Lixte Biotechnology’s LB-100 to Enter Recurrent Malignant Brain Tumors
December 04, 2019 09:35 ET
|
Lixte Biotechnology Holdings, Inc.
EAST SETAUKET, NY, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced that the National Cancer Institute (NCI) has enrolled the first two patients of a...
First Patient Enrolled in Phase 1b/2 Trial of Lixte Biotechnology’s LB-100 in Low or Intermediate-1 Risk Myelodysplastic Syndrome
July 18, 2019 09:35 ET
|
Lixte Biotechnology Holdings, Inc.
EAST SETAUKET, NY, July 18, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced that the first patient has been enrolled in its Phase 1b/2 study of the safety and...
Lixte Biotechnology's LB-100 to be Evaluated by the National Cancer Institute in a Clinical Study of LB-100's Ability to Enter Recurrent Glioblastoma Multiforme Brain Tumors
May 15, 2019 09:35 ET
|
Lixte Biotechnology Holdings, Inc.
EAST SETAUKET, NY, May 15, 2019 (GLOBE NEWSWIRE) -- Lixte Biotechnology Holdings, Inc. (OTCQB: LIXT) announced the opening of a pharmacologic study of the ability of its lead clinical compound,...
Karmanos Cancer Institute presents 25th Annual Partners Night Friday, Sept. 21, at historic Michigan Building Theatre
August 23, 2018 07:05 ET
|
Barbara Ann Karmanos Cancer Institute
Honoring Jack D. Sobel, M.D.; Celebrating Partners silver anniversary of supporting Karmanos’ cutting-edge cancer research DETROIT, Aug. 23, 2018 (GLOBE NEWSWIRE) -- On Friday, Sept. 21, the...
Karmanos Cancer Institute hosts inaugural Prostate Cancer Awareness Game at Jimmy John’s Field, August 17
July 25, 2018 07:05 ET
|
Barbara Ann Karmanos Cancer Institute
DETROIT, July 25, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute, in partnership with McLaren Macomb Foundation, joins the United Shore Baseball League for the inaugural Karmanos...
Karmanos Expands Cancer Network with Newest Location at McLaren Oakland
July 23, 2018 10:00 ET
|
Barbara Ann Karmanos Cancer Institute
PONTIAC, Mich., July 23, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute and McLaren Oakland announced today it will open its 15th treatment location in Michigan at McLaren...
Karmanos Cancer Institute to begin renovations to expand services in Farmington Hills
May 18, 2018 08:10 ET
|
Barbara Ann Karmanos Cancer Institute
DETROIT, May 18, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute announced today it will expand its Lawrence and Idell Weisberg Cancer Treatment Center in Farmington Hills into a...
Cofactor Genomics announces new collaboration with the National Cancer Institute (NCI) to demonstrate power of RNA-based immune profiling assay
March 20, 2018 08:30 ET
|
Cofactor Genomics
SAN FRANCISCO, March 20, 2018 (GLOBE NEWSWIRE) -- Cofactor Genomics, leading developer of advanced RNA analysis tools, announced today that they have entered into an agreement with the National...
Barbara Ann Karmanos Cancer Institute receives 2018 Women’s Choice Award® as one of America’s Best Hospitals for Cancer Care & Research
January 23, 2018 13:42 ET
|
Barbara Ann Karmanos Cancer Institute
DETROIT, Jan. 23, 2018 (GLOBE NEWSWIRE) -- The Barbara Ann Karmanos Cancer Institute has been named one of America’s Best Hospitals for Cancer Care & Research by the Women’s Choice Award® for...
Karmanos Cancer Institute and Wayne State University conduct Community-Engaged Research symposium Feb. 5
January 11, 2018 13:47 ET
|
Barbara Ann Karmanos Cancer Institute
DETROIT, Jan. 11, 2018 (GLOBE NEWSWIRE) -- Cardiovascular disease is the leading cause of death in the United States and cancer is the second, with higher rates of diagnosis and death in...